| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 7.37 mm | 7.37 mm | 7.37 mm | 7.37 mm | 7.37 mm | 7.37 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.88 mm | 3.13 mm | 344.40 k | 269.78 k |
| Cash used (since last report) | n/a | n/a | 53.47 mm | 88.98 mm | 9.78 mm | 7.66 mm |
| Cash remaining | n/a | n/a | -46.10 mm | -81.61 mm | -2.41 mm | -289.86 k |
| Runway (months of cash) | n/a | n/a | -24.5 | -26.0 | -7.0 | -1.1 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 35.36 mm |
| Total shares | 8.50 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Lena Pharma | 4.25 mm | $17.68 mm |
| Lisa Pharma | 4.25 mm | $17.68 mm |
